

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.87521160 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.36357557 |
| 3 | keratinization (GO:0031424) | 4.02553224 |
| 4 | cerebellar granule cell differentiation (GO:0021707) | 3.99949131 |
| 5 | positive regulation of synapse maturation (GO:0090129) | 3.92036804 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91818693 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.82866928 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.67115088 |
| 9 | neuronal ion channel clustering (GO:0045161) | 3.64734854 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.58082328 |
| 11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.53602314 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52256957 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 3.42818552 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42818552 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 3.40284046 |
| 16 | neurotransmitter secretion (GO:0007269) | 3.37327767 |
| 17 | regulation of ARF protein signal transduction (GO:0032012) | 3.35633510 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 3.31705564 |
| 19 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.25502758 |
| 20 | potassium ion homeostasis (GO:0055075) | 3.25278024 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.24710526 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.24710526 |
| 23 | regulation of synapse maturation (GO:0090128) | 3.18242077 |
| 24 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16155303 |
| 25 | lysine metabolic process (GO:0006553) | 3.12772556 |
| 26 | lysine catabolic process (GO:0006554) | 3.12772556 |
| 27 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.10704724 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.09898548 |
| 29 | desmosome organization (GO:0002934) | 3.09403999 |
| 30 | cellular sodium ion homeostasis (GO:0006883) | 3.03982607 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.03156443 |
| 32 | positive regulation of fatty acid oxidation (GO:0046321) | 3.02232848 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02053495 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 3.01643437 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.01503285 |
| 36 | glutamate metabolic process (GO:0006536) | 3.01161991 |
| 37 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.00024367 |
| 38 | carnitine shuttle (GO:0006853) | 2.98670751 |
| 39 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98352573 |
| 40 | reverse cholesterol transport (GO:0043691) | 2.97140382 |
| 41 | cysteine metabolic process (GO:0006534) | 2.94436726 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 2.89061774 |
| 43 | short-chain fatty acid metabolic process (GO:0046459) | 2.86630478 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86316719 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 2.86108499 |
| 46 | myelination in peripheral nervous system (GO:0022011) | 2.84571348 |
| 47 | peripheral nervous system axon ensheathment (GO:0032292) | 2.84571348 |
| 48 | aspartate family amino acid catabolic process (GO:0009068) | 2.83282691 |
| 49 | bile acid biosynthetic process (GO:0006699) | 2.79710934 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 2.79641950 |
| 51 | fatty acid beta-oxidation (GO:0006635) | 2.78531573 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.78211843 |
| 53 | amino acid import (GO:0043090) | 2.77456557 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76669430 |
| 55 | kynurenine metabolic process (GO:0070189) | 2.74853978 |
| 56 | myelin maintenance (GO:0043217) | 2.74325851 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 2.73040982 |
| 58 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72539576 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 2.71035828 |
| 60 | dicarboxylic acid catabolic process (GO:0043649) | 2.69828184 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 2.69170572 |
| 62 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.68564731 |
| 63 | fatty acid homeostasis (GO:0055089) | 2.68387085 |
| 64 | ethanol oxidation (GO:0006069) | 2.67829987 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 2.67551569 |
| 66 | alanine transport (GO:0032328) | 2.67439384 |
| 67 | regulation of p38MAPK cascade (GO:1900744) | 2.67202803 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.66215144 |
| 69 | glyoxylate metabolic process (GO:0046487) | 2.66066406 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 2.65844168 |
| 71 | phospholipid homeostasis (GO:0055091) | 2.64965469 |
| 72 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.64156228 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 2.63642187 |
| 74 | cellular glucuronidation (GO:0052695) | 2.63469946 |
| 75 | lipid oxidation (GO:0034440) | 2.62325310 |
| 76 | establishment of skin barrier (GO:0061436) | 2.62159479 |
| 77 | fatty acid oxidation (GO:0019395) | 2.62087942 |
| 78 | neuronal action potential propagation (GO:0019227) | 2.62072481 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 2.61726894 |
| 80 | acylglycerol homeostasis (GO:0055090) | 2.60603794 |
| 81 | triglyceride homeostasis (GO:0070328) | 2.60603794 |
| 82 | * regulation of cholesterol homeostasis (GO:2000188) | 2.60169144 |
| 83 | hormone catabolic process (GO:0042447) | 2.59603294 |
| 84 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.58985670 |
| 85 | L-amino acid import (GO:0043092) | 2.58120833 |
| 86 | peptide cross-linking (GO:0018149) | 2.56649532 |
| 87 | neurotransmitter transport (GO:0006836) | 2.56425524 |
| 88 | fatty acid catabolic process (GO:0009062) | 2.56424601 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 2.55898229 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 2.55898229 |
| 91 | macromolecular complex remodeling (GO:0034367) | 2.55898229 |
| 92 | xenobiotic catabolic process (GO:0042178) | 2.55156691 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 2.54770607 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.54747581 |
| 95 | glutamate secretion (GO:0014047) | 2.54580961 |
| 96 | cell communication by electrical coupling (GO:0010644) | 2.53993087 |
| 97 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.53473076 |
| 98 | homocysteine metabolic process (GO:0050667) | 2.51657273 |
| 99 | regulation of water loss via skin (GO:0033561) | 2.51174655 |
| 100 | complement activation, alternative pathway (GO:0006957) | 2.50887358 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 2.50552085 |
| 102 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.50281480 |
| 103 | alpha-amino acid catabolic process (GO:1901606) | 2.49712162 |
| 104 | response to gravity (GO:0009629) | 2.49412592 |
| 105 | tryptophan catabolic process (GO:0006569) | 2.49298934 |
| 106 | indole-containing compound catabolic process (GO:0042436) | 2.49298934 |
| 107 | indolalkylamine catabolic process (GO:0046218) | 2.49298934 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 2.48416029 |
| 109 | phospholipid efflux (GO:0033700) | 2.47600075 |
| 110 | sodium ion export (GO:0071436) | 2.47367743 |
| 111 | regulation of protein activation cascade (GO:2000257) | 2.47234827 |
| 112 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.46840543 |
| 113 | neuromuscular process controlling balance (GO:0050885) | 2.46460219 |
| 114 | skin morphogenesis (GO:0043589) | 2.45796110 |
| 115 | skeletal muscle adaptation (GO:0043501) | 2.45794966 |
| 116 | chemosensory behavior (GO:0007635) | 2.45611840 |
| 117 | urea metabolic process (GO:0019627) | 2.45350562 |
| 118 | urea cycle (GO:0000050) | 2.45350562 |
| 119 | lung epithelium development (GO:0060428) | 2.45177138 |
| 120 | vocalization behavior (GO:0071625) | 2.44370604 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44356864 |
| 122 | flavonoid metabolic process (GO:0009812) | 2.43958337 |
| 123 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.43407287 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43257962 |
| 125 | striated muscle hypertrophy (GO:0014897) | 2.42796029 |
| 126 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.42001788 |
| 127 | coenzyme catabolic process (GO:0009109) | 2.41520782 |
| 128 | biotin metabolic process (GO:0006768) | 2.41248467 |
| 129 | carnitine metabolic process (GO:0009437) | 2.40935831 |
| 130 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.40751140 |
| 131 | glucuronate metabolic process (GO:0019585) | 2.40712581 |
| 132 | uronic acid metabolic process (GO:0006063) | 2.40712581 |
| 133 | positive regulation of protein dephosphorylation (GO:0035307) | 2.40497489 |
| 134 | cell communication involved in cardiac conduction (GO:0086065) | 2.39089936 |
| 135 | creatine metabolic process (GO:0006600) | 2.39083892 |
| 136 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38419071 |
| 137 | protein carboxylation (GO:0018214) | 2.38419071 |
| 138 | negative regulation of fibrinolysis (GO:0051918) | 2.37949774 |
| 139 | bile acid metabolic process (GO:0008206) | 2.37815110 |
| 140 | nitrogen cycle metabolic process (GO:0071941) | 2.37232063 |
| 141 | regulation of complement activation (GO:0030449) | 2.36873603 |
| 142 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.36453288 |
| 143 | activation of protein kinase A activity (GO:0034199) | 2.36309322 |
| 144 | detection of calcium ion (GO:0005513) | 2.36297002 |
| 145 | ketone body metabolic process (GO:1902224) | 2.36276416 |
| 146 | carnitine transmembrane transport (GO:1902603) | 2.36215400 |
| 147 | locomotory exploration behavior (GO:0035641) | 2.36184580 |
| 148 | cerebellar Purkinje cell layer development (GO:0021680) | 2.35886948 |
| 149 | regulation of triglyceride metabolic process (GO:0090207) | 2.35754275 |
| 150 | keratinocyte proliferation (GO:0043616) | 2.35634890 |
| 151 | regulation of sequestering of triglyceride (GO:0010889) | 2.35176371 |
| 152 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.34484308 |
| 153 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.34136835 |
| 154 | regulation of early endosome to late endosome transport (GO:2000641) | 2.33972309 |
| 155 | protein targeting to plasma membrane (GO:0072661) | 2.33339749 |
| 156 | potassium ion import (GO:0010107) | 2.33298622 |
| 157 | regulation of female receptivity (GO:0045924) | 2.32371706 |
| 158 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.29213016 |
| 159 | macroautophagy (GO:0016236) | 2.28599039 |
| 160 | cell volume homeostasis (GO:0006884) | 2.26268164 |
| 161 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.25450743 |
| 162 | phosphate ion transmembrane transport (GO:0035435) | 2.25433854 |
| 163 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.23881760 |
| 164 | activation of MAPKKK activity (GO:0000185) | 2.23773718 |
| 165 | synaptic vesicle endocytosis (GO:0048488) | 2.23382826 |
| 166 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.22939920 |
| 167 | regulation of vesicle fusion (GO:0031338) | 2.22605672 |
| 168 | regulation of cell communication by electrical coupling (GO:0010649) | 2.21562097 |
| 169 | regulation of neurotransmitter levels (GO:0001505) | 2.20806077 |
| 170 | multicellular organismal water homeostasis (GO:0050891) | 2.18970978 |
| 171 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.18088025 |
| 172 | regulation of neurotransmitter secretion (GO:0046928) | 2.17444625 |
| 173 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.14953000 |
| 174 | negative regulation of stress fiber assembly (GO:0051497) | 2.14837044 |
| 175 | glomerular basement membrane development (GO:0032836) | 2.14593610 |
| 176 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.14527908 |
| 177 | positive regulation of dendritic spine development (GO:0060999) | 2.14199687 |
| 178 | positive regulation of neurotransmitter transport (GO:0051590) | 2.13919690 |
| 179 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.11963843 |
| 180 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.11192348 |
| 181 | peptidyl-proline hydroxylation (GO:0019511) | 2.10581125 |
| 182 | focal adhesion assembly (GO:0048041) | 2.10527591 |
| 183 | cell-substrate adherens junction assembly (GO:0007045) | 2.10527591 |
| 184 | positive regulation of membrane potential (GO:0045838) | 2.10035360 |
| 185 | protein localization to endosome (GO:0036010) | 2.10021985 |
| 186 | cardiac muscle contraction (GO:0060048) | 2.09951763 |
| 187 | muscle hypertrophy (GO:0014896) | 2.09597207 |
| 188 | axon ensheathment in central nervous system (GO:0032291) | 2.09396084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.58851519 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39323585 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38369464 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89016278 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86571448 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83527404 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66237521 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.44250493 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14479170 |
| 10 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10080874 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06056523 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94142040 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87028782 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84132303 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81970723 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.78525202 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74968143 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.72233639 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70239255 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70239255 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69334401 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66901962 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66108084 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65878444 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62789698 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.62575449 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62119722 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61859235 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58030603 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57382111 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55803048 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55181572 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54678974 |
| 34 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51126253 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48422671 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46934763 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45922557 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45810262 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41199976 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41071157 |
| 41 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40354195 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39383592 |
| 43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39042747 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38813786 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38217906 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37682033 |
| 47 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.36397429 |
| 48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36055546 |
| 49 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33100622 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32948422 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32010548 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31359445 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31227395 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28510030 |
| 55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28138396 |
| 56 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28029656 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27746222 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26675490 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26580657 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26248218 |
| 61 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26107738 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25589139 |
| 63 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23953907 |
| 64 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23728220 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23008213 |
| 66 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22780508 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21504925 |
| 68 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21294036 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18025191 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17672166 |
| 71 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16966991 |
| 72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16779431 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15274077 |
| 74 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13745567 |
| 75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13664309 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.12944013 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12692342 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12614903 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11375269 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10289857 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09667933 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08520010 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06300695 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05249537 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05249537 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04422783 |
| 87 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02417678 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02339912 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01983855 |
| 90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01493120 |
| 91 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01316385 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01188678 |
| 93 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00467174 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98413540 |
| 95 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98255872 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97905657 |
| 97 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97905351 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97527142 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97516655 |
| 100 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97396352 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95749661 |
| 102 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95693205 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95653671 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95558900 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95558900 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95291880 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94861059 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93669523 |
| 109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93640402 |
| 110 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93187506 |
| 111 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91746803 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91080308 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90242853 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90175822 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87128335 |
| 116 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86625413 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86371108 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85841205 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85743915 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85346304 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85143000 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85126989 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85034219 |
| 124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83667327 |
| 125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83374931 |
| 126 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.83132992 |
| 127 | * AR_19668381_ChIP-Seq_PC3_Human | 0.82942758 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81980078 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81574670 |
| 130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80365439 |
| 131 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80071313 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79235228 |
| 133 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79124367 |
| 134 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78011912 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77387652 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76226601 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76066646 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75735751 |
| 139 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.75137540 |
| 140 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75065188 |
| 141 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.74825985 |
| 142 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.73583402 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72343859 |
| 144 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.71978819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.22543519 |
| 2 | MP0005360_urolithiasis | 3.95442377 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 3.38136323 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.27929126 |
| 5 | * MP0005365_abnormal_bile_salt | 3.11717017 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.07156245 |
| 7 | * MP0010329_abnormal_lipoprotein_level | 2.53537831 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.46369530 |
| 9 | MP0004130_abnormal_muscle_cell | 2.44405443 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.31913950 |
| 11 | MP0002796_impaired_skin_barrier | 2.30017582 |
| 12 | MP0009840_abnormal_foam_cell | 2.28406815 |
| 13 | MP0003646_muscle_fatigue | 2.23155537 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.22382509 |
| 15 | MP0004885_abnormal_endolymph | 2.21309744 |
| 16 | MP0000751_myopathy | 2.19959897 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.17879327 |
| 18 | MP0005275_abnormal_skin_tensile | 2.15434056 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.07766188 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.07102251 |
| 21 | MP0003878_abnormal_ear_physiology | 2.07102251 |
| 22 | MP0005670_abnormal_white_adipose | 2.04018999 |
| 23 | MP0003252_abnormal_bile_duct | 2.01310391 |
| 24 | MP0003880_abnormal_central_pattern | 1.92714190 |
| 25 | MP0005409_darkened_coat_color | 1.92441305 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.85810079 |
| 27 | MP0005332_abnormal_amino_acid | 1.85501035 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.79127250 |
| 29 | MP0002254_reproductive_system_inflammat | 1.76460315 |
| 30 | MP0004510_myositis | 1.72181523 |
| 31 | MP0003329_amyloid_beta_deposits | 1.71743710 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.69647469 |
| 33 | MP0002822_catalepsy | 1.69005630 |
| 34 | * MP0002118_abnormal_lipid_homeostasis | 1.67572334 |
| 35 | MP0000579_abnormal_nail_morphology | 1.64879647 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.63601630 |
| 37 | MP0005083_abnormal_biliary_tract | 1.62332207 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.58482865 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.52711746 |
| 40 | MP0000920_abnormal_myelination | 1.47149789 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.43848241 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.41725726 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.41700105 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.41563007 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.41212854 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.40623507 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.39624784 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.39558496 |
| 49 | MP0003690_abnormal_glial_cell | 1.35403731 |
| 50 | MP0000749_muscle_degeneration | 1.35167133 |
| 51 | MP0003045_fibrosis | 1.33606976 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.32321367 |
| 53 | MP0002090_abnormal_vision | 1.32221547 |
| 54 | MP0003195_calcinosis | 1.29667385 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.27684420 |
| 56 | * MP0000759_abnormal_skeletal_muscle | 1.27477159 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.27284842 |
| 58 | MP0004270_analgesia | 1.25906331 |
| 59 | MP0004043_abnormal_pH_regulation | 1.25457868 |
| 60 | MP0005330_cardiomyopathy | 1.25235837 |
| 61 | MP0005620_abnormal_muscle_contractility | 1.23360563 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.23217899 |
| 63 | MP0002971_abnormal_brown_adipose | 1.21508170 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.21446772 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.19161879 |
| 66 | MP0003011_delayed_dark_adaptation | 1.18160463 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.15765110 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.14965854 |
| 69 | MP0002734_abnormal_mechanical_nocicepti | 1.14728687 |
| 70 | MP0005451_abnormal_body_composition | 1.14236385 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.14094848 |
| 72 | MP0004085_abnormal_heartbeat | 1.13988356 |
| 73 | MP0005535_abnormal_body_temperature | 1.12408697 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.12171976 |
| 75 | MP0009745_abnormal_behavioral_response | 1.11022387 |
| 76 | MP0002063_abnormal_learning/memory/cond | 1.10243711 |
| 77 | MP0002064_seizures | 1.09477819 |
| 78 | MP0003137_abnormal_impulse_conducting | 1.09213575 |
| 79 | MP0003075_altered_response_to | 1.08768537 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.08762593 |
| 81 | * MP0004087_abnormal_muscle_fiber | 1.08749180 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.08531372 |
| 83 | * MP0000609_abnormal_liver_physiology | 1.06933582 |
| 84 | MP0006138_congestive_heart_failure | 1.06919470 |
| 85 | MP0005501_abnormal_skin_physiology | 1.06522642 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05819476 |
| 87 | MP0003566_abnormal_cell_adhesion | 1.04472300 |
| 88 | MP0002060_abnormal_skin_morphology | 1.03227702 |
| 89 | MP0002269_muscular_atrophy | 1.02934547 |
| 90 | * MP0001502_abnormal_circadian_rhythm | 1.02643816 |
| 91 | MP0002108_abnormal_muscle_morphology | 1.01847120 |
| 92 | MP0009046_muscle_twitch | 1.01482618 |
| 93 | MP0003123_paternal_imprinting | 1.00962948 |
| 94 | MP0000604_amyloidosis | 1.00852211 |
| 95 | MP0005058_abnormal_lysosome_morphology | 1.00481869 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.99472350 |
| 97 | MP0001984_abnormal_olfaction | 0.97643250 |
| 98 | MP0001486_abnormal_startle_reflex | 0.95560371 |
| 99 | MP0008569_lethality_at_weaning | 0.95533756 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.94690264 |
| 101 | MP0005023_abnormal_wound_healing | 0.94194820 |
| 102 | MP0005369_muscle_phenotype | 0.93725486 |
| 103 | MP0002572_abnormal_emotion/affect_behav | 0.92886817 |
| 104 | MP0003633_abnormal_nervous_system | 0.91347041 |
| 105 | MP0003634_abnormal_glial_cell | 0.90577032 |
| 106 | MP0003868_abnormal_feces_composition | 0.90462170 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.90357800 |
| 108 | MP0001958_emphysema | 0.89986708 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.89219568 |
| 110 | MP0002933_joint_inflammation | 0.89095176 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.89023892 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.89023892 |
| 113 | MP0004858_abnormal_nervous_system | 0.88363174 |
| 114 | MP0004484_altered_response_of | 0.88071819 |
| 115 | MP0003091_abnormal_cell_migration | 0.86667493 |
| 116 | MP0005334_abnormal_fat_pad | 0.85752638 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.85646417 |
| 118 | MP0000747_muscle_weakness | 0.85401724 |
| 119 | MP0004272_abnormal_basement_membrane | 0.84931813 |
| 120 | MP0002272_abnormal_nervous_system | 0.84896307 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.84797317 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.84484945 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.83982912 |
| 124 | MP0005166_decreased_susceptibility_to | 0.83855812 |
| 125 | MP0001970_abnormal_pain_threshold | 0.83572644 |
| 126 | MP0003879_abnormal_hair_cell | 0.82891197 |
| 127 | MP0004233_abnormal_muscle_weight | 0.82707276 |
| 128 | MP0008874_decreased_physiological_sensi | 0.82425486 |
| 129 | MP0003631_nervous_system_phenotype | 0.80175939 |
| 130 | MP0008872_abnormal_physiological_respon | 0.79804188 |
| 131 | MP0003279_aneurysm | 0.79188558 |
| 132 | MP0005448_abnormal_energy_balance | 0.78769588 |
| 133 | MP0001440_abnormal_grooming_behavior | 0.77541953 |
| 134 | MP0000750_abnormal_muscle_regeneration | 0.76034431 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.74730434 |
| 136 | MP0004947_skin_inflammation | 0.74727922 |
| 137 | MP0000733_abnormal_muscle_development | 0.74204329 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.73637522 |
| 139 | MP0000003_abnormal_adipose_tissue | 0.73618055 |
| 140 | MP0001851_eye_inflammation | 0.73606148 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.73571223 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.72914222 |
| 143 | MP0008775_abnormal_heart_ventricle | 0.72697960 |
| 144 | MP0002127_abnormal_cardiovascular_syste | 0.72286314 |
| 145 | MP0005165_increased_susceptibility_to | 0.72279784 |
| 146 | MP0000762_abnormal_tongue_morphology | 0.71843986 |
| 147 | MP0000566_synostosis | 0.71658023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.55289579 |
| 2 | Xanthomatosis (HP:0000991) | 3.90782056 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.84048456 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.61736049 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 3.61668614 |
| 6 | Diplopia (HP:0000651) | 3.59335386 |
| 7 | Abnormality of binocular vision (HP:0011514) | 3.59335386 |
| 8 | Hyperglycinuria (HP:0003108) | 3.56822769 |
| 9 | Ketoacidosis (HP:0001993) | 3.49115977 |
| 10 | Ketosis (HP:0001946) | 3.46534612 |
| 11 | Exercise-induced myalgia (HP:0003738) | 3.46485591 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.42068564 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.39514424 |
| 14 | Myoglobinuria (HP:0002913) | 3.33846159 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.32042851 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 3.29691279 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.23755436 |
| 18 | Hyperammonemia (HP:0001987) | 3.18866918 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.15997221 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15997221 |
| 21 | Complement deficiency (HP:0004431) | 2.99895685 |
| 22 | Sudden death (HP:0001699) | 2.99652665 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 2.94422896 |
| 24 | Hyperglycinemia (HP:0002154) | 2.89797163 |
| 25 | Muscle fiber inclusion bodies (HP:0100299) | 2.86267217 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 2.86203245 |
| 27 | Action tremor (HP:0002345) | 2.86035801 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.83189355 |
| 29 | Protrusio acetabuli (HP:0003179) | 2.82943150 |
| 30 | Nemaline bodies (HP:0003798) | 2.81702112 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.76140555 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75238296 |
| 33 | Axonal loss (HP:0003447) | 2.69786629 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.69619549 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.66249086 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.63930159 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.61472868 |
| 38 | Ankle clonus (HP:0011448) | 2.61107760 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60887695 |
| 40 | Gout (HP:0001997) | 2.60550141 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.57744720 |
| 42 | Hyperventilation (HP:0002883) | 2.56452831 |
| 43 | Epidermoid cyst (HP:0200040) | 2.55792618 |
| 44 | Abnormality of nail color (HP:0100643) | 2.55340207 |
| 45 | Syncope (HP:0001279) | 2.53215269 |
| 46 | Lower limb amyotrophy (HP:0007210) | 2.48347061 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47691562 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.45524761 |
| 49 | Prolonged QT interval (HP:0001657) | 2.45061331 |
| 50 | Dysmetric saccades (HP:0000641) | 2.44067070 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 2.43085694 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42632833 |
| 53 | Focal motor seizures (HP:0011153) | 2.42444273 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42269069 |
| 55 | Atrioventricular block (HP:0001678) | 2.41614676 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.39253253 |
| 57 | Hypobetalipoproteinemia (HP:0003563) | 2.38864009 |
| 58 | Central scotoma (HP:0000603) | 2.38238248 |
| 59 | Skin nodule (HP:0200036) | 2.38225150 |
| 60 | Atrial fibrillation (HP:0005110) | 2.37516496 |
| 61 | Bundle branch block (HP:0011710) | 2.37034698 |
| 62 | Febrile seizures (HP:0002373) | 2.35957249 |
| 63 | Annular pancreas (HP:0001734) | 2.33159685 |
| 64 | Heart block (HP:0012722) | 2.32290147 |
| 65 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30941704 |
| 66 | Abnormality of the salivary glands (HP:0010286) | 2.29790805 |
| 67 | EMG: myopathic abnormalities (HP:0003458) | 2.29769365 |
| 68 | Abnormal atrioventricular conduction (HP:0005150) | 2.29002165 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28548299 |
| 70 | Ventricular tachycardia (HP:0004756) | 2.27197577 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 2.26829998 |
| 72 | Atonic seizures (HP:0010819) | 2.26448426 |
| 73 | Muscle fiber splitting (HP:0003555) | 2.25566832 |
| 74 | Shallow orbits (HP:0000586) | 2.24630503 |
| 75 | Round ear (HP:0100830) | 2.21293140 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.21130392 |
| 77 | Hyperkalemia (HP:0002153) | 2.18497600 |
| 78 | Primary atrial arrhythmia (HP:0001692) | 2.17422782 |
| 79 | Status epilepticus (HP:0002133) | 2.16998669 |
| 80 | Cholelithiasis (HP:0001081) | 2.15934808 |
| 81 | Myopathic facies (HP:0002058) | 2.15296295 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.14810764 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.14045370 |
| 84 | Polycythemia (HP:0001901) | 2.12770595 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 2.11983796 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.11670358 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 2.11208375 |
| 88 | Increased IgE level (HP:0003212) | 2.11149096 |
| 89 | Rigidity (HP:0002063) | 2.11126112 |
| 90 | Spinal rigidity (HP:0003306) | 2.10442863 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.10369536 |
| 92 | Epileptic encephalopathy (HP:0200134) | 2.09964069 |
| 93 | Abnormality of the calf musculature (HP:0001430) | 2.09781586 |
| 94 | Palpitations (HP:0001962) | 2.09765133 |
| 95 | Late onset (HP:0003584) | 2.08658619 |
| 96 | Calf muscle hypertrophy (HP:0008981) | 2.07691618 |
| 97 | Torticollis (HP:0000473) | 2.07643629 |
| 98 | Metabolic acidosis (HP:0001942) | 2.07275874 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.06585540 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 2.06585540 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 2.06585540 |
| 102 | Papilledema (HP:0001085) | 2.06389976 |
| 103 | Truncal ataxia (HP:0002078) | 2.06248289 |
| 104 | Tetraplegia (HP:0002445) | 2.06094490 |
| 105 | Cerebral aneurysm (HP:0004944) | 2.05780907 |
| 106 | Postural instability (HP:0002172) | 2.05164269 |
| 107 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04678155 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 2.03854440 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.03569649 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03569649 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 2.03509902 |
| 112 | Myokymia (HP:0002411) | 2.03386985 |
| 113 | Hypercortisolism (HP:0001578) | 2.03270701 |
| 114 | Increased connective tissue (HP:0009025) | 2.02916545 |
| 115 | Dysmetria (HP:0001310) | 2.02753122 |
| 116 | Polar cataract (HP:0010696) | 2.02538220 |
| 117 | Alacrima (HP:0000522) | 2.02515958 |
| 118 | Acanthosis nigricans (HP:0000956) | 2.02164380 |
| 119 | Supraventricular tachycardia (HP:0004755) | 2.00498331 |
| 120 | Depression (HP:0000716) | 1.98220200 |
| 121 | Hyperglycemia (HP:0003074) | 1.98203737 |
| 122 | Delayed CNS myelination (HP:0002188) | 1.97978242 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.97707353 |
| 124 | Abnormality of purine metabolism (HP:0004352) | 1.97190671 |
| 125 | Myotonia (HP:0002486) | 1.97165301 |
| 126 | Broad metatarsal (HP:0001783) | 1.97039442 |
| 127 | Supraventricular arrhythmia (HP:0005115) | 1.96917246 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 1.96896596 |
| 129 | Upper limb amyotrophy (HP:0009129) | 1.96896596 |
| 130 | Abnormality of complement system (HP:0005339) | 1.96457035 |
| 131 | Hypercholesterolemia (HP:0003124) | 1.96249163 |
| 132 | Rapidly progressive (HP:0003678) | 1.95965967 |
| 133 | Difficulty running (HP:0009046) | 1.95270747 |
| 134 | Dysdiadochokinesis (HP:0002075) | 1.94459063 |
| 135 | Visual hallucinations (HP:0002367) | 1.93086645 |
| 136 | Abnormality of the foot musculature (HP:0001436) | 1.91624301 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91487940 |
| 138 | Nuclear cataract (HP:0100018) | 1.90471570 |
| 139 | Sleep apnea (HP:0010535) | 1.90114565 |
| 140 | Glomerulonephritis (HP:0000099) | 1.89837656 |
| 141 | Fat malabsorption (HP:0002630) | 1.89049022 |
| 142 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88644703 |
| 143 | Hydroxyprolinuria (HP:0003080) | 1.86218635 |
| 144 | Abnormality of proline metabolism (HP:0010907) | 1.86218635 |
| 145 | Achilles tendon contracture (HP:0001771) | 1.84199856 |
| 146 | Scotoma (HP:0000575) | 1.84094819 |
| 147 | Focal seizures (HP:0007359) | 1.83794755 |
| 148 | Insomnia (HP:0100785) | 1.82595500 |
| 149 | Bronchomalacia (HP:0002780) | 1.82454668 |
| 150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.82411866 |
| 151 | Congenital stationary night blindness (HP:0007642) | 1.82192867 |
| 152 | Hyperparathyroidism (HP:0000843) | 1.82173283 |
| 153 | EMG: neuropathic changes (HP:0003445) | 1.81430975 |
| 154 | Neck muscle weakness (HP:0000467) | 1.81027690 |
| 155 | Neurofibrillary tangles (HP:0002185) | 1.80264484 |
| 156 | Muscle stiffness (HP:0003552) | 1.79729305 |
| 157 | Corneal erosion (HP:0200020) | 1.79716071 |
| 158 | Abnormal gallbladder physiology (HP:0012438) | 1.79471917 |
| 159 | Cholecystitis (HP:0001082) | 1.79471917 |
| 160 | Generalized tonic-clonic seizures (HP:0002069) | 1.78339283 |
| 161 | Vascular tortuosity (HP:0004948) | 1.78338322 |
| 162 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78108811 |
| 163 | Oligomenorrhea (HP:0000876) | 1.78092403 |
| 164 | Impaired social interactions (HP:0000735) | 1.77977718 |
| 165 | Difficulty climbing stairs (HP:0003551) | 1.75568210 |
| 166 | Absence seizures (HP:0002121) | 1.75100528 |
| 167 | Intention tremor (HP:0002080) | 1.71798871 |
| 168 | Hypoplasia of the iris (HP:0007676) | 1.71142750 |
| 169 | Peripheral hypomyelination (HP:0007182) | 1.70632002 |
| 170 | Abnormality of the Achilles tendon (HP:0005109) | 1.69406741 |
| 171 | Focal dystonia (HP:0004373) | 1.69282321 |
| 172 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67151042 |
| 173 | Spinal canal stenosis (HP:0003416) | 1.67139135 |
| 174 | Slow saccadic eye movements (HP:0000514) | 1.66714698 |
| 175 | Growth hormone excess (HP:0000845) | 1.65704314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.13207834 |
| 2 | EPHA4 | 3.04098097 |
| 3 | LMTK2 | 2.69557936 |
| 4 | BCKDK | 2.54468161 |
| 5 | PHKG1 | 2.36963116 |
| 6 | PHKG2 | 2.36963116 |
| 7 | SIK1 | 2.23475655 |
| 8 | DAPK2 | 2.06223269 |
| 9 | INSRR | 1.99898089 |
| 10 | ERN1 | 1.92907913 |
| 11 | CDK12 | 1.92896056 |
| 12 | RIPK1 | 1.88241225 |
| 13 | PRKD3 | 1.87299521 |
| 14 | PINK1 | 1.87195390 |
| 15 | ARAF | 1.86150694 |
| 16 | DMPK | 1.73213131 |
| 17 | UHMK1 | 1.69781804 |
| 18 | TTN | 1.68307362 |
| 19 | EPHA2 | 1.56406473 |
| 20 | MAP3K13 | 1.56176961 |
| 21 | MAP2K4 | 1.55894480 |
| 22 | MARK2 | 1.55209571 |
| 23 | MYLK | 1.54995396 |
| 24 | PDK3 | 1.41748077 |
| 25 | PDK4 | 1.41748077 |
| 26 | CASK | 1.41112472 |
| 27 | TESK1 | 1.40305491 |
| 28 | SGK3 | 1.40007270 |
| 29 | SGK2 | 1.37872731 |
| 30 | NTRK3 | 1.32349817 |
| 31 | CAMK1D | 1.31089128 |
| 32 | STK38 | 1.30281798 |
| 33 | ICK | 1.29123120 |
| 34 | MAP3K4 | 1.27857288 |
| 35 | SGK223 | 1.22963892 |
| 36 | SGK494 | 1.22963892 |
| 37 | MAP3K7 | 1.22388900 |
| 38 | CAMK1G | 1.20630688 |
| 39 | MAP3K2 | 1.19756571 |
| 40 | MARK1 | 1.17481574 |
| 41 | PAK6 | 1.17385061 |
| 42 | MOS | 1.17327494 |
| 43 | MAPK12 | 1.17322233 |
| 44 | CAMKK1 | 1.17111134 |
| 45 | CDC42BPA | 1.16300616 |
| 46 | TIE1 | 1.15272348 |
| 47 | NTRK2 | 1.11079177 |
| 48 | MUSK | 1.09269279 |
| 49 | PDK2 | 1.04747472 |
| 50 | OBSCN | 1.03787501 |
| 51 | FGFR4 | 1.01329580 |
| 52 | PTK2B | 1.00175238 |
| 53 | TRPM7 | 0.97475605 |
| 54 | PKN2 | 0.96597562 |
| 55 | TAOK1 | 0.96164860 |
| 56 | CAMK2B | 0.94954607 |
| 57 | PAK3 | 0.94586459 |
| 58 | PRKD2 | 0.93978525 |
| 59 | WNK1 | 0.93897082 |
| 60 | MAP3K9 | 0.92495104 |
| 61 | PIK3CA | 0.91282856 |
| 62 | LATS1 | 0.91190048 |
| 63 | PRKCH | 0.87097001 |
| 64 | PDPK1 | 0.86426269 |
| 65 | FER | 0.86054373 |
| 66 | CAMK1 | 0.85435727 |
| 67 | SIK2 | 0.84965807 |
| 68 | RIPK4 | 0.83895772 |
| 69 | MAPK15 | 0.83585373 |
| 70 | EPHB1 | 0.82652811 |
| 71 | PRPF4B | 0.82272223 |
| 72 | HIPK2 | 0.82110633 |
| 73 | MAPK7 | 0.80436898 |
| 74 | KSR2 | 0.79642049 |
| 75 | MAP2K7 | 0.79635222 |
| 76 | AKT3 | 0.78926497 |
| 77 | CAMKK2 | 0.78517725 |
| 78 | PRKAA2 | 0.78249856 |
| 79 | WNK4 | 0.77781482 |
| 80 | EEF2K | 0.77715240 |
| 81 | FGFR2 | 0.77381701 |
| 82 | CAMK4 | 0.77222722 |
| 83 | RET | 0.73304977 |
| 84 | PRKD1 | 0.72712213 |
| 85 | ROCK1 | 0.71074293 |
| 86 | CDK5 | 0.70040371 |
| 87 | MAP2K1 | 0.68430728 |
| 88 | PDGFRA | 0.67906610 |
| 89 | MINK1 | 0.67869408 |
| 90 | PRKAA1 | 0.67542529 |
| 91 | CAMK2A | 0.66577704 |
| 92 | MAP3K1 | 0.65633853 |
| 93 | NTRK1 | 0.65431336 |
| 94 | IRAK3 | 0.65146540 |
| 95 | SIK3 | 0.64932237 |
| 96 | TAOK2 | 0.64731799 |
| 97 | LIMK1 | 0.64419976 |
| 98 | PDK1 | 0.64162628 |
| 99 | IRAK2 | 0.64129080 |
| 100 | MAP3K6 | 0.62996741 |
| 101 | MAP3K11 | 0.62347174 |
| 102 | STK38L | 0.62295135 |
| 103 | MAPKAPK3 | 0.61990848 |
| 104 | BRAF | 0.61779235 |
| 105 | PTK6 | 0.61643769 |
| 106 | PTK2 | 0.61352416 |
| 107 | CAMK2D | 0.61075588 |
| 108 | MAPK10 | 0.59471950 |
| 109 | NEK1 | 0.59290293 |
| 110 | NEK6 | 0.59259500 |
| 111 | CAMK2G | 0.57961199 |
| 112 | MTOR | 0.57146842 |
| 113 | SGK1 | 0.57086442 |
| 114 | GRK5 | 0.57046560 |
| 115 | MAP2K3 | 0.54466060 |
| 116 | MAP2K6 | 0.54410800 |
| 117 | PRKACG | 0.53157176 |
| 118 | MST1R | 0.52558898 |
| 119 | FGFR3 | 0.52286896 |
| 120 | PRKCG | 0.51922559 |
| 121 | LATS2 | 0.51004566 |
| 122 | DDR2 | 0.50384837 |
| 123 | MET | 0.49562772 |
| 124 | BMX | 0.49440886 |
| 125 | MAPK4 | 0.48268349 |
| 126 | PRKCE | 0.46684720 |
| 127 | MAP3K3 | 0.45759683 |
| 128 | PDGFRB | 0.45663485 |
| 129 | PRKCZ | 0.44730068 |
| 130 | OXSR1 | 0.44381523 |
| 131 | DAPK1 | 0.44125613 |
| 132 | EPHA3 | 0.43927333 |
| 133 | SMG1 | 0.43469030 |
| 134 | ERBB4 | 0.43446482 |
| 135 | TYRO3 | 0.43423778 |
| 136 | STK11 | 0.43030866 |
| 137 | JAK1 | 0.42395927 |
| 138 | ROCK2 | 0.41469248 |
| 139 | RPS6KA2 | 0.41256553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.16118954 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60642505 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.47268629 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45611411 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.33422070 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08201965 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07299526 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04418465 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96089460 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93850363 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.87765237 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87605541 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87502009 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86179777 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83141405 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81487892 |
| 17 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.71213541 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67255351 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.65908653 |
| 20 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51997826 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49977918 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.47883703 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44878160 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37085725 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33664255 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30313526 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.29118376 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.28953298 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28079120 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27122524 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26623291 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25603785 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24281007 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22413259 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20314383 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19295811 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18218674 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17046078 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16949700 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14062707 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12934340 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.12753919 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.11258496 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07781902 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06781433 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04330050 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99648277 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.97837396 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97132510 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96951704 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96371282 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.96219759 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95830903 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94275640 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92750330 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92409067 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92374247 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92321459 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91245146 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91042130 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 0.88992477 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87222055 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85754640 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85637949 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.84846257 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84671627 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.84352617 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84314300 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82774585 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.82117215 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81605649 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81553535 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81319067 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.81083688 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81027672 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80918396 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80421092 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.80088972 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.79028041 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78895260 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77804269 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77414823 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76681133 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75957734 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75904362 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75664668 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75410992 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75251728 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74835642 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74374581 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.73081210 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72825041 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72778903 |
| 94 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.72526684 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72394316 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71042265 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68949996 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68341791 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67553893 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67247912 |
| 101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66983887 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65800865 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.65036763 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.64281290 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62791485 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62629813 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62186490 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.62103926 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61641276 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.60444326 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60301555 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60231147 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59752790 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59535327 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59299820 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58396315 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58284256 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58097135 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57566950 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56466195 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55472712 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55241874 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54467673 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.54274913 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53620513 |
| 126 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53241010 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53196611 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50806731 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50576736 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49694837 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49622034 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48207745 |
| 133 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47671293 |
| 134 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47007087 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46997380 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46525968 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45901868 |
| 138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45815490 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45566351 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45082027 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44460285 |
| 142 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44100043 |
| 143 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43754749 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42380421 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40660204 |
| 146 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39694269 |
| 147 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38983596 |
| 148 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38764996 |
| 149 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37881787 |
| 150 | Taste transduction_Homo sapiens_hsa04742 | 0.37874859 |
| 151 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37734024 |
| 152 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37143824 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37099037 |

